NASDAQ · Biotechnology

CGTX (CGTX) Stock

$0.89 +0.21% NASDAQ: CGTX Healthcare

Valuation

MetricValue
Price$0.89
Market Cap$79.79M
P/E Ratio-3.94
P/B Ratio2.73
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$3.83
52-Week Low$0.25
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-67.65%
ROA-47.92%
ROCE-141.18%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.02
Current Ratio3.43

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-29.0M$-44.0M$-51.0M$-54.0M$-48.0M
Net Profit$-12.0M$1.0M$-26.0M$-34.0M$-23.0M
EPS$-0.73$-0.74$-0.86$-0.85$-0.32
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$59.0M$50.0M$35.0M$30.0M$48.0M
Total Liabilities$8.0M$10.0M$11.0M$11.0M$14.0M
Cash$55.0M$42.0M$30.0M$25.0M$37.0M
Borrowings$0$1.0M$1.0M$1.0M$1.0M

Latest News

Cognition Therapeutics Participating in Fireside Chat at B. Riley Securities' Mind, Muscle & Vision Summit GlobeNewswire · Jul 13, 2026 Cognition Therapeutics Gets Positive FDA Feedback Over Phase 3 Study Of DLB Psychosis – But CGTX Stock Just Crashed 33% Stocktwits · Jun 24, 2026 Cognition Therapeutics Advances After FDA Supports Key Elements of Pivotal Trial Plan (CGTX) InvestorsHub · Jun 24, 2026 Cognition Therapeutics Agrees With FDA on Phase 3 Trial Framework for Psychosis Treatment MT Newswires · Jun 24, 2026 Cognition Therapeutics Aligns on Key Aspects of Pivotal Study for Zervimesine (CT1812) in DLB Psychosis Following Receipt of FDA Meeting Minutes GlobeNewswire · Jun 24, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-4.0M$-19.0M$-16.0M$-28.0M$-25.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$9.0M$2.0M$0$0$0
Net Cash Flow$50.0M$-13.0M$-12.0M$-5.0M$12.0M
Free Cash Flow$-4.0M$-19.0M$-16.0M$-28.0M$-25.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-21.84%
Quick Ratio5.92
Interest Coverage—
Return 1Y65.49%
Return 3Y-45.66%
Return 5Y—

Ownership

Insiders Held1.37%
Institutions Held25.02%
Institutions Float Held25.36%
Institutional HolderSharesReport Date
Bios Capital Management, LP 6,000,0002026-03-31
Davenport & Co LLC4,259,5112026-06-30
Vanguard Capital Management LLC3,001,7872026-03-31
Renaissance Technologies, LLC1,117,1362026-03-31
Chescapmanager LLC997,0292026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AGENAgenus Inc. $6.06 +1.34% 3.46 $252.35M 0.00%
ATOS $2.36 -2.48% -1.23 $23.54M 0.00%
GLSI $14.36 +0.84% -21.98 $210.78M 0.00%
IRDOpus Genetics, Inc. $3.32 +7.63% -2.35 $273.71M 0.00%
MCRB $4.65 -3.12% 11.97 $45.03M 0.00%

About CGTX

CGTX is led by CEO Lisa Ricciardi, employs 25 people, headquartered in US, publicly traded since 2021.

CGTX stock trades at $0.89 with a market capitalization of $79.79M. The stock is valued at a price-to-earnings (P/E) ratio of -3.94, price-to-book of 2.73, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.25 and $3.83, and currently trades 76.8% below its 52-week high.

On profitability, CGTX generates a return on equity (ROE) of -67.65%, return on capital employed of -141.18%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides